Search for content, post, videos

Ultimovacs receives Notice of Allowance on US Patent

Carlos de Sousa
Ultimovacs has received a Notice of Allowance from the United States Patent and Trademarks Office (USPTO) concerning its US patent application on the use of vaccine-checkpoint inhibitor combinations to treat cancer. Subject to grant formalities, it is expected that a patent will issue with a pate
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.